View
225
Download
0
Category
Preview:
Citation preview
8/3/2019 Ranbaxy and Daiichi Acquisitio
1/28
8/3/2019 Ranbaxy and Daiichi Acquisitio
2/28
! !#
3.47547,90/3
#,30/,24389909450307..425,3083
9047/
74:3/4507,94383.4:39708,3/2,3:1,.9:734507,94383.4:39708
54798.4397-:9094,74:3/41949,
70;03:08
8570894-0.420,7080,7.-,80/5,72,.0:9.,.425,3370;03:0841-3-
3;8438-0.423,9450307.85,07-
8/3/2019 Ranbaxy and Daiichi Acquisitio
3/28
! !#
# $#
479207.,
:7450
3/,
2073
,7098
0;0450/,7098
9078
#0;03:0;0781.,943
$,704/3-014700,
,9047 4/3
!74249078
42089.
3899:9438
8
$,704/3,19070,
,9047 4/3
,. $,34
#089
8/3/2019 Ranbaxy and Daiichi Acquisitio
4/28
#' %#$ # %
fn
O nffn
O Jffnff
O fnn
O ffnnn
fnffffffnf
nfnnfnnf
ffnnfnff
8/3/2019 Ranbaxy and Daiichi Acquisitio
5/28
$!$% %
fnffnfnffff
nffffnfff
ffffnf
ffn ffffnfnf
O 9nff9
O 9fff
O nf
O nffffff
fffnf
8/3/2019 Ranbaxy and Daiichi Acquisitio
6/28
$!$% %
nn,fn
ffnf fnfn
fnf
@nfnf
ff#fffnn-ffnnff
nnn
fnffffnfnnfn
f#9ffnff
nff,fn%
8/3/2019 Ranbaxy and Daiichi Acquisitio
7/28
% $$ ! %
@ffff
,ff,ff
ffnff
ffff
ffffffff@ff
%fnffn%fffnf%f
ff
@n%@nf
fffffff
@#ff
f
8/3/2019 Ranbaxy and Daiichi Acquisitio
8/28
&$'% '#
#
@fn
@ff-#ffff
f
@fff
@f
fnf
O f
O nfffnf
O fffnff
f
O ffff
8/3/2019 Ranbaxy and Daiichi Acquisitio
9/28
& % % % %
nffnfnffnn
nfff
O nfnfff
O ffnfnfn
nf
O nfffn#f
8/3/2019 Ranbaxy and Daiichi Acquisitio
10/28
'& #%
nfnffff
nfffn
ffnnf
fffnffff
ff ffffn
fnff
fnffnnfnn
n ff
ffnfnnfnff nffnfnffnn
nfffffff
8/3/2019 Ranbaxy and Daiichi Acquisitio
11/28
%
f
-f
f @
@f
9
8/3/2019 Ranbaxy and Daiichi Acquisitio
12/28
% $ # #%$
f
9
I$@
8/3/2019 Ranbaxy and Daiichi Acquisitio
13/28
#83
47 90
7
,709
!7.0
43,7
441$,708
09$,08
093.420
,709
',:0416:9
'093.420
'09$,08
#
#
$&
I,I$-f,I$
,@IDJ-@9
@@99
8/3/2019 Ranbaxy and Daiichi Acquisitio
14/28
'&% $% !%
W fff
W nffnf
fnnff
W @
!
#8700#,90#1
6:9#8!702:2#2#1
09,
4891 6:90 #109,#2#1
0
8/3/2019 Ranbaxy and Daiichi Acquisitio
15/28
'&% $$&!%$
#%7
%,
473 ,59,0503/9:70
4109$,08
,504109$,08
,84742507,9438 4109$,08
749 309$,08
%,73
7493 9507509:9
8/3/2019 Ranbaxy and Daiichi Acquisitio
16/28
'&%
# #83
$:241!'41 97
!'41%'
09/0-9.,8
884.,9083;08920398
503,9#8,88:25943#88,70
%0.:8;9!'#8 8,70
'&%$ 4418,70848 23
'&%$#8$,70
If$@f9nff
8/3/2019 Ranbaxy and Daiichi Acquisitio
17/28
$#$ # %
ffnf
ff
8/3/2019 Ranbaxy and Daiichi Acquisitio
18/28
$#$ # %
nnf
8/3/2019 Ranbaxy and Daiichi Acquisitio
19/28
$#$ # %
%%#&$$$
&$##%
8/3/2019 Ranbaxy and Daiichi Acquisitio
20/28
ffnfnf
8/3/2019 Ranbaxy and Daiichi Acquisitio
21/28
$#$ # %
n f
n
8/3/2019 Ranbaxy and Daiichi Acquisitio
22/28
$#$ # %
,ffnnff
8/3/2019 Ranbaxy and Daiichi Acquisitio
23/28
$#$ # %
Wnff
W@
f f
8/3/2019 Ranbaxy and Daiichi Acquisitio
24/28
% ## &%
%,,94388:0
,3/574-0
,.41050798037:333,4-,-:83088
%0050.90/8307082,349.420974: 7488:9:7,88:08
0,88:08
.4342./439:73
8/3/2019 Ranbaxy and Daiichi Acquisitio
25/28
!$% ## %#%
%7,38,.943,570,8438147
,:70W;07459289.,557,8,41
2,709549039,
W;070892,94341830708
W;07-//3
#@fffff
W9fnf
W9ffnf
nf
Wnfn
Wffnffff
fff
nf
Wnnffnf
fff
8/3/2019 Ranbaxy and Daiichi Acquisitio
26/28
$ #
nffnn
fff
n
fnf
nfn
n
nffff
nfnfnf
ffnf
nffnffnf
fffffff
nn
8/3/2019 Ranbaxy and Daiichi Acquisitio
27/28
% $ $&$$&
%#%
8/3/2019 Ranbaxy and Daiichi Acquisitio
28/28
Recommended